Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects
-
Source:
Science (New York, N.Y.) [Science] 2024 Jun 14; Vol. 384 (6701), pp. 1164-1165. Date of Electronic Publication: 2024 Jun 13.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication
Record details
-
Authors :
Cohen IG; Professor of Law, Harvard Law School, Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, MA 02138, USA.; Adashi EY
Subjects: Genome, Human* ; Germ Cells*; Embryo Research/Embryo Research/Embryo Research/*legislation & jurisprudence
-
Source:
Science (New York, N.Y.) [Science] 2016 Aug 05; Vol. 353 (6299), pp. 545-6.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication
Record details